Platelets Protect Cardiomyocytes from Ischemic Damage

 

 Permissions and Reprints

Abstract

Platelets are classically known for their roles in bleeding control and occlusive thrombus formation causing ischemic tissue damage. Recently, nonclassical roles for platelets have been described, many of which may be mediated by the heterogeneous cargo that platelets secrete from granular stores upon activation. Using an in vitro model of ischemic injury to ventricular cardiomyocytes, we observed that platelets, through secreted factors, delayed the rate of cardiomyocyte death during ischemia. This protective effect appeared independent of platelet dense granule cargo, but required α-granule components stromal cell-derived factor-1α and transforming growth factor-β1. Protein kinase C activity within cardiomyocytes was responsible for mediating the protective signals initiated by the released platelet cargo. Importantly, pretreating platelets with a P2Y₁₂ antagonist, but not the cyclooxygenase inhibitor aspirin, substantially attenuated this protective effect. These findings therefore reveal a paradoxically protective role for platelet activation during cardiac ischemia and could have important implications for the use of antiplatelet therapeutics in the management of myocardial infarction.

Funding

This work was funded by grants from the British Heart Foundation to A.W.P. (PG/13/14/30023, RG/10/006/28299, RG/15/16/31758).

• References

• 1 Rafii S, Cao Z, Lis R. , et al. Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration. Nat Cell Biol 2015; 17 (02) 123-136
  CrossrefPubMedGoogle Scholar
• 2 Lynch SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci U S A 1987; 84 (21) 7696-7700
  CrossrefPubMedGoogle Scholar
• 3 Xiang B, Zhang G, Guo L. , et al. Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun 2013; 4: 2657
  CrossrefPubMedGoogle Scholar
• 4 Jørgensen L. The role of platelets in the initial stages of atherosclerosis. J Thromb Haemost 2006; 4 (07) 1443-1449
  CrossrefPubMedGoogle Scholar
• 5 Ho-Tin-Noé B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008; 68 (16) 6851-6858
  CrossrefPubMedGoogle Scholar
• 6 Nieswandt B, Hafner M, Echtenacher B, Männel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999; 59 (06) 1295-1300
  PubMedGoogle Scholar
• 7 Coppinger JA, Cagney G, Toomey S. , et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004; 103 (06) 2096-2104
  CrossrefPubMedGoogle Scholar
• 8 Golebiewska EM, Poole AW. Secrets of platelet exocytosis - what do we really know about platelet secretion mechanisms?. Br J Haematol 2013; 165 (02) 204-216
  CrossrefPubMedGoogle Scholar
• 9 Walsh TG, Metharom P, Berndt MC. The functional role of platelets in the regulation of angiogenesis. Platelets 2015; 26 (03) 199-211
  CrossrefPubMedGoogle Scholar
• 10 Pachel C, Mathes D, Arias-Loza AP. , et al. Inhibition of platelet glycoprotein VI protects against myocardial ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 2016; 36 (04) 629-635
  CrossrefPubMedGoogle Scholar
• 11 Devanathan V, Hagedorn I, Köhler D. , et al. Platelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice. Proc Natl Acad Sci U S A 2015; 112 (20) 6491-6496
  CrossrefPubMedGoogle Scholar
• 12 Yang BC, Mehta JL. Platelet-derived adenosine contributes to the cardioprotective effects of platelets against ischemia-reperfusion injury in isolated rat heart. J Cardiovasc Pharmacol 1994; 24 (05) 779-785
  CrossrefPubMedGoogle Scholar
• 13 Yang BC, Virmani R, Nichols WW, Mehta JL. Platelets protect against myocardial dysfunction and injury induced by ischemia and reperfusion in isolated rat hearts. Circ Res 1993; 72 (06) 1181-1190
  CrossrefPubMedGoogle Scholar
• 14 Parodi EM, Kuhn B. Signalling between microvascular endothelium and cardiomyocytes through neuregulin. Cardiovasc Res 2014; 102 (02) 194-204
  CrossrefPubMedGoogle Scholar
• 15 Harper MT, van den Bosch MT, Hers I, Poole AW. Absence of platelet phenotype in mice lacking the motor protein myosin Va. PLoS One 2013; 8 (01) e53239
  CrossrefPubMedGoogle Scholar
• 16 Vander Heide RS, Rim D, Hohl CM, Ganote CE. An in vitro model of myocardial ischemia utilizing isolated adult rat myocytes. J Mol Cell Cardiol 1990; 22 (02) 165-181
  CrossrefPubMedGoogle Scholar
• 17 Wang F, He Q, Sun Y, Dai X, Yang XP. Female adult mouse cardiomyocytes are protected against oxidative stress. Hypertension 2010; 55 (05) 1172-1178
  CrossrefPubMedGoogle Scholar
• 18 Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 2004; 61 (03) 498-511
  CrossrefPubMedGoogle Scholar
• 19 Savage JS, Williams CM, Konopatskaya O, Hers I, Harper MT, Poole AW. Munc13-4 is critical for thrombosis through regulating release of ADP from platelets. J Thromb Haemost 2013; 11 (04) 771-775
  CrossrefPubMedGoogle Scholar
• 20 Hu X, Dai S, Wu WJ. , et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 2007; 116 (06) 654-663
  CrossrefPubMedGoogle Scholar
• 21 Yang BC, Zander DS, Mehta JL. Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-beta(1). J Pharmacol Exp Ther 1999; 291 (02) 733-738
  PubMedGoogle Scholar
• 22 Döring Y, Pawig L, Weber C, Noels H. The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. Front Physiol 2014; 5: 212
  PubMedGoogle Scholar
• 23 Koitabashi N, Danner T, Zaiman AL. , et al. Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. J Clin Invest 2011; 121 (06) 2301-2312
  CrossrefPubMedGoogle Scholar
• 24 Gardiner EE, De Luca M, McNally T, Michelson AD, Andrews RK, Berndt MC. Regulation of P-selectin binding to the neutrophil P-selectin counter-receptor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G. Blood 2001; 98 (05) 1440-1447
  CrossrefPubMedGoogle Scholar
• 25 Henn V, Slupsky JR, Gräfe M. , et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391 (6667): 591-594
  CrossrefPubMedGoogle Scholar
• 26 Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74 (05) 1124-1136
  CrossrefPubMedGoogle Scholar
• 27 Armstrong S, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia. Cardiovasc Res 1994; 28 (11) 1700-1706
  CrossrefPubMedGoogle Scholar
• 28 Armstrong SC, Kao R, Gao W. , et al. Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: effects of a protein phosphatase inhibitor, fostriecin. J Mol Cell Cardiol 1997; 29 (11) 3009-3024
  CrossrefPubMedGoogle Scholar
• 29 Ren Q, Wimmer C, Chicka MC. , et al. Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis. Blood 2010; 116 (06) 869-877
  CrossrefPubMedGoogle Scholar
• 30 King SM, McNamee RA, Houng AK, Patel R, Brands M, Reed GL. Platelet dense-granule secretion plays a critical role in thrombosis and subsequent vascular remodeling in atherosclerotic mice. Circulation 2009; 120 (09) 785-791
  CrossrefPubMedGoogle Scholar
• 31 Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5′-nucleotidase (CD73). Purinergic Signal 2006; 2 (02) 351-360
  CrossrefPubMedGoogle Scholar
• 32 Heijnen H, van der Sluijs P. Platelet secretory behaviour: as diverse as the granules … or not?. J Thromb Haemost 2015; 13 (12) 2141-2151
  CrossrefPubMedGoogle Scholar
• 33 Jonnalagadda D, Izu LT, Whiteheart SW. Platelet secretion is kinetically heterogeneous in an agonist-responsive manner. Blood 2012; 120 (26) 5209-5216
  CrossrefPubMedGoogle Scholar
• 34 Italiano Jr JE, Richardson JL, Patel-Hett S. , et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008; 111 (03) 1227-1233
  PubMedGoogle Scholar
• 35 Gong Q, Pitas RE. Synergistic effects of growth factors on the regulation of smooth muscle cell scavenger receptor activity. J Biol Chem 1995; 270 (37) 21672-21678
  CrossrefPubMedGoogle Scholar
• 36 Fryer RM, Pratt PF, Hsu AK, Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001; 296 (02) 642-649
  PubMedGoogle Scholar
• 37 Kunuthur SP, Mocanu MM, Hemmings BA, Hausenloy DJ, Yellon DM. The Akt1 isoform is an essential mediator of ischaemic preconditioning. J Cell Mol Med 2012; 16 (08) 1739-1749
  CrossrefPubMedGoogle Scholar
• 38 Fryer RM, Schultz JE, Hsu AK, Gross GJ. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol 1999; 276 (4, Pt 2): H1229-H1235
  PubMedGoogle Scholar
• 39 Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266 (3, Pt 2): H1145-H1152
  PubMedGoogle Scholar
• 40 Lim JY, Park SJ, Hwang HY. , et al. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J Mol Cell Cardiol 2005; 39 (04) 627-636
  CrossrefPubMedGoogle Scholar
• 41 Odemis V, Boosmann K, Dieterlen MT, Engele J. The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCzeta. J Cell Sci 2007; 120 (Pt 22): 4050-4059
  CrossrefPubMedGoogle Scholar
• 42 Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 2007; 1767 (08) 1007-1031
  CrossrefPubMedGoogle Scholar
• 43 Suzuki M, Sasaki N, Miki T. , et al. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 2002; 109 (04) 509-516
  CrossrefPubMedGoogle Scholar
• 44 Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 2010; 9 (02) 154-169
  CrossrefPubMedGoogle Scholar
• 45 Fu Y, Wang Z, Chen WL, Moore PK, Zhu YZ. Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats. Am J Physiol Heart Circ Physiol 2007; 293 (03) H1545-H1552
  CrossrefPubMedGoogle Scholar
• 46 Bell RM, Sivaraman V, Kunuthur SP, Cohen MV, Downey JM, Yellon DM. Cardioprotective properties of the platelet P2Y12 receptor inhibitor, Cangrelor: protective in diabetics and reliant upon the presence of blood. Cardiovasc Drugs Ther 2015; 29 (05) 415-418
  CrossrefPubMedGoogle Scholar
• 47 Ye Y, Birnbaum GD, Perez-Polo JR, Nanhwan MK, Nylander S, Birnbaum Y. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol 2015; 35 (08) 1805-1814
  CrossrefPubMedGoogle Scholar
• 48 Nanhwan MK, Ling S, Kodakandla M, Nylander S, Ye Y, Birnbaum Y. Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect. Arterioscler Thromb Vasc Biol 2014; 34 (09) 2078-2085
  CrossrefPubMedGoogle Scholar
• 49 Diaz RJ, Wilson GJ. Studying ischemic preconditioning in isolated cardiomyocyte models. Cardiovasc Res 2006; 70 (02) 286-296
  CrossrefPubMedGoogle Scholar
• 50 Ma L, Elliott SN, Cirino G, Buret A, Ignarro LJ, Wallace JL. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A 2001; 98 (11) 6470-6475
  CrossrefPubMedGoogle Scholar

• Supplementary Material